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Cervical cancer screening has evolved throughout the years into the current, 
very effective, algorithms for screening and management. The success of improved 
early detection of cervical cancer has saved many lives (Lees, Erickson, & Huh, 
2016). The addition of human papillomavirus testing and genotyping has allowed for 
more efficient, and less invasive, management of cervical cancer screening (Cox, 
2009). While there are significant advantages to these new guidelines, there are 
barriers to applying them in practice. The clinical site for the project was identified to 
be in need of a quality improvement project aimed at creating an improved patient 
notification, tracking and reminder system as well as improving provider adherence 
with the evidence-based guidelines. There were 48 total eligible providers that were 
included in the project. 
After identification of the problem, a review of the literature was undertaken to 
identify an evidence-based strategy for addressing practice gaps. This literature review 
focused on provider guideline adherence with cervical cancer screening guidelines and 
patient notification, tracking and reminder systems. Current literature demonstrates a 
gap in provider guideline adherence nationwide as well as strategies aimed at 
improving both provider and patient adherence with the reccomendations. These 
iv 
 
include use of consistent patient notification processes, implementation of an 
electronic tracking and reminder system, and provider educational sessions aimed at 
improving guideline compliance. Donabedian’s (2005) quality improvement 
framework was utilized to divide the literature findings into those interventions that 
effect outcomes, structure, and process of care in order to form the project plan and 
methods. 
Following this in-depth look at the background and existing literature, the 
project plan was established. The plan consisted of two phases: the first focusing on 
creation of project materials and preparation for project implementation, and the 
second focusing on the roll out of the new process and data collection for project 
analysis. Two objectives were identified for this project: improve provider adherence 
to the 2012 American Society of Colposcopy and Cervical Pathology Guidelines and 
implementation of an electronic patient notification, tracking and reminder system. A 
plan for data collection and analysis through pre- and post-implementation provider 
surveys and chart audits was established. 
After project implementation, data collection and analysis occurred. Objective 
One was evaluated in order to determine if the project implementation correlated with 
an increase in provider guideline adherence. The quality improvement project did find 
an improvement in guideline adherence in recommending appropriate follow-up for 
patients following receipt of cervical cancer screening results. For their survey 
responses on a series of patient vignettes, as well as whether patients were actually 
screened at an appropriate interval according to the recommendations, the providers 
were not found to show a statistical improvement following implementation of the 
project. In evaluating Objective Two, there was found to be moderate compliance on 
v 
 
the part of the providers with the new process in the weeks following project 
implementation. Nursing participants in the new process were found to be 100% 
compliant with following the process. No statistical difference was found in provider 
beliefs regarding the practice’s tracking and reminder system pre- and post-
intervention. Limitations existed in this study that limit the ability of the researcher to 
make assumptions based on the findings. Regardless, this project served to address the 
need for a robust notification tracking and reminder system. This system helps to 
ensure that patients receive timely, clear, and concise communication regarding their 
cervical cancer screening results and what these results mean for them. Additionally, 
they are notified and reminded to follow-up as needed. This is all done in an attempt to 
continue to drive down cervical cancer rates while also reducing unnecessary, and 
costly, procedures and testing. 
Keywords: cervical cancer screening, guideline adherence, tracking and 
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Cervical cancer was, at one time, undetectable until it had progressed to the point 
that survival was unlikely and treatment options were few (Centers for Disease Control 
and Prevention, 2017). Research on methods of early detection have led to evidence-
based guidelines for the screening and management of cervical cancer. While these 
guidelines and screening options have reduced mortality associated with this type of 
cancer, they are complex and difficult for providers and practices to adhere to. Chapter I 
serves to introduce the background and significance of this problem and the purpose of 
the Doctor of Nursing Practice (DNP) scholarly project. 
Background and Significance 
Invasive cervical cancer was once the leading cause of cancer-related death in 
women (Centers for Disease Control and Prevention, 2017). In an effort to find a way to 
detect cervical cancer early, Dr. George Papanicolaou began researching cervical and 
vaginal sampling in the 1920s (Lees, Erickson, & Huh, 2016). He developed and 
established the screening test now known as the Pap test and published his research in 
1941 (Lees et al., 2016). As practitioners began adopting the Pap test routinely and 
annual screening became mainstream, cervical cancer death rates began to fall. During 
the years of 1950 to 1970, mortality rates dropped an astonishing 3% per year (Lees et 




The Pap test began as a method of screening in which a sample of cells is taken 
from the cervix and placed on a slide for microscopic evaluation (Lees et al., 2016). It has 
since evolved to what is known today as liquid cervical cytology, in which the sample is 
placed in a preservative liquid and then is sent for pathology evaluation (Lippincott 
Procedures, 2017). The cells are observed for any changes that could be precancerous and 
are evaluated for maturity, morphology, and metabolic activity (Lippincott Procedures, 
2017). These results are then sent to the provider noting the presence, if any, of abnormal 
cells as well as type of cell that is found. The type of abnormal cell noted helps the 
provider determine which risk category the patient falls into and to determine future 
follow-up. Despite the success of annual cervical cytology testing, the test itself was 
found to be a poor predictor of future cervical cancer (Lees et al., 2016). Pap testing has 
been identified to have a specificity of 98% with a sensitivity of only 51% (Lees et al., 
2016). To account for its high false negative rate, annual screening was necessary in 
order to continue to drive down cervical cancer rates (Lees et al., 2016).  
In an effort to identify improved screening practices, scientists began 
investigating the causes of the dysplastic changes that were occurring in cells, and in 
1976 a causative effect between infection with the virus human papillomavirus (HPV) 
and dysplastic changes in cervical cells was found (Cox, 2009). In 1983, Dr. Harald zur 
Hausen isolated the high-risk HPV strain, HPV 16 and later HPV 18, which are now 
known as the strains that account for up to 70% of cases of cervical cancer (Lees et al., 
2016). Twelve additional high-risk strains have since been identified, adding up to a total 




Once HPV was identified to be the cause of cervical cancer development, the 
focus shifted to determining what this meant for screening guidelines. In the late 1980s, 
there were two simultaneous landmark studies done that investigated the role of HPV 
testing in routine screening (Cox, 2009). Once the Food and Drug Administration 
approved the first test for HPV, ViraPap, it was used in a trial in conjunction with repeat 
Pap and colposcopy in patients who had been referred to colposcopy following abnormal 
Pap results at a student health center (Cox, 2009). Of the 482 patients who had been 
referred for colposcopy, only 262 (54%) would have required colposcopy using the 
criteria of either a positive HPV test or abnormal cytology instead of the presence of 
atypical cells alone (Cox, 2009). For study participants with an abnormal finding of 
atypical squamous cells of undetermined significance, using HPV testing to determine the 
need for colposcopy would have further reduced the total procedures necessary to 178 of 
the original 482 (37%), while still maintaining a clinically low rate of missing cervical 
intra-epithelial neoplasia (Cox, 2009). At the completion of Cox’s study, it was identified 
that HPV testing could be used in conjunction with Pap testing, referred to as co-testing, 
to safely determine whether colposcopy is necessary (Cox, 2009).  
While HPV has been exclusively linked to cervical cancer, not all HPV infections 
lead to cancer and many do not need to be treated. Up to 90% of HPV infections will 
clear spontaneously within one to two years of initial infection (Lees et al., 2016). The 
HPV infections that persist or that are associated with certain cervical cytology changes 
now allow providers to use past screening results in conjunction with current results to 
place patients into risk categories and determine appropriate follow-up based on level of 




Pathology (ASCCP) guidelines are based on these factors, among others, and give a 
thorough, yet complicated, series of follow-up and routine screening recommendations. 
The use of co-testing, cervical cytology combined with high-risk HPV testing, 
was first implemented into the algorithm for the management of atypical squamous cells 
of undetermined significance (ASC-US) (Cox, 2009). This category of results was the 
most common abnormal finding from Pap testing and led to a high number of 
unnecessary colposcopies that resulted in normal findings (Cox, 2009). On the other side 
of this issue, ASC-US is associated with a higher risk of future development of cervical 
intraepithelial neoplasia, leaving providers in need of a way to determine which patients 
with a finding of ASC-US required further evaluation (Cox, 2009). Further research 
supported using HPV testing to triage ASC-US results into those who required treatment 
and those who were likely to resolve without intervention (Cox, 2009). In 2012, both the 
ASCCP as well as the American College of Obstetrics and Gynecologists released 
guidelines incorporating HPV genotyping into the long-standing solitary Pap testing 
guidelines and decreased the frequency of screenings for certain low risk groups (Cox, 
2009).  
The advantages of these new guidelines were significant: fewer and more targeted 
screenings without fear of increased numbers of late stage cervical cancer. The 
savings associated with these new guidelines might not only be in healthcare 
expenditures, but in the time spent on unnecessary screening in an era where 
widespread shortages of primary care providers exist. (Boone, Lewis, & Karp, 
2016, p. 261) 
 
Emerging research is focusing on the role of high-risk HPV testing alone as primary 
screening (Lees et al., 2016). In 2014, the United States Food and Drug Administration 
approved the first HPV genotyping test for primary screening of cervical cancer in 




released amended guidelines that allowed for the option of HPV genotyping alone for 
routine screening in certain populations (Baker, 2017). Many countries around the world 
have already made the move to fully utilize primary HPV testing to screen the population 
either for all patients or for certain populations based on age and geographical location 
(Baker, 2017). These include the Netherlands, Denmark, Sweden, and Italy (Baker, 
2017). Additionally, the discovery and manufacture of the HPV vaccine that vaccinates 
against several strains of HPV, including the high-risk HPV 16 and HPV 18, pose further 
questions about the future of HPV and cervical cancer screening (Lees et al., 2016) (see 
Appendix A for a Cervical Cancer Screening Timeline).  
If properly followed, the guidelines present an evidence-based approach to 
screening that limits unnecessary procedures while maintaining a low risk of missing 
invasive cervical cancer. The increased intervals in the guidelines are to allow for the 
transient nature of HPV infection and reduce the risks of over screening, with the primary 
risk being unnecessary procedures such as colposcopies (Cox, 2009). A literature review 
of 16 studies regarding psychological after effects of colposcopy found that there is an 
increased risk of psychological distress, particularly anxiety, following colposcopy 
(O’Connor et al., 2015). An additional study done in Ireland found that four out of five 
respondents reported experiencing at least one negative physical after affect, either 
bleeding, pain, or discharge, at a four-month questionnaire following colposcopy 
(O’Connor et al., 2015). Proper adherence to the guidelines reduces the risks associated 
with unnecessary procedures for patients in addition to reducing the cost, both time and 




In the face of rapidly changing evidence on which to base practice, there have 
been many changes to screening in primary care. The current set of algorithms, while 
evidence-based and scientifically shown to improve outcomes, are complicated and rely 
on a series of information, including prior cervical cytology and genotyping, in order to 
determine an appropriate follow-up recommendation. In addition to a complex system of 
determining follow-up care, there are cultural factors that influence a lack of adherence 
with the guidelines including fear of litigation and management of patient perceptions 
(Teoh et al., 2015). Finally, the move from an easy to manage system of annual screening 
to a myriad of follow-up options ranging from several weeks to five years with a variety 
of follow-up procedures necessary has led to providers, and practices as a whole, 
struggling to establish a notification, tracking and reminder system that will improve 
compliance with the recommended follow-up for both providers and patients (Dupuis et 
al., 2010). 
Problem Statement 
In a primary care organization, there was a need identified for a quality 
improvement project regarding cervical cancer screening. The current state was a manual 
tracking and reminder system for the whole practice and an opportunity for improvement 
in provider guideline adherence. A quality improvement project was necessary in order to 
assess the current state of guideline adherence and implement interventions to address 
any gaps identified as well as to create an improved patient notification, tracking and 






Q For providers in a primary care practice, does implementation of an 
educational session in conjunction with an electronic patient notification, 
tracking and reminder system, as compared to the usual care and tracking 
system in use, increase adherence to the 2012 American Society for 













REVIEW OF THE LITERATURE 
The literature review was divided into two categories: provider guideline 
adherence and patient notification, tracking and reminder systems (see Appendix B for 
the literature review matrix). Databases searched included Cumulative Index of Nursing 
and Allied Health Literature, Cochrane, Google Scholar, and PubMed databases. Articles 
found were rated by level of evidence as noted in the literature review table (Melnyk & 
Fineout-Overholt, 2015). This section is a synthesis of the literature review by category.  
Provider Compliance with Recommendations 
 
Search terms for this section of the literature review included guideline adherence 
and cervical cancer screening guideline adherence. The original search found over 
400,000 articles. The modifiers of provider, full text available, and earliest publication 
date of 2007 were added to narrow the search. Articles that focused on patient 
compliance components and those that focused on adherence to older versions of the 
guidelines were excluded. Additionally, research that focused solely on adherence by 
providers who specialize in gynecology were excluded as the population for this quality 
improvement study is a primary care practice. Over 100 articles were reviewed in total. 
Of those, eight were included in the final literature review. A summary of these findings 
is included below. 
In 2013, a cross sectional survey of 124 providers found that overall compliance 




guidelines had changed. Sixty-three providers reported that they always comply with the 
new guidelines; however, of those only seven were able to correctly answer all of the 
knowledge-based questions on the survey. This indicates a knowledge and practice gap 
between what the evidence supports and what is actually happening in practice. Providers 
who indicated that they were not following the guidelines indicated reasons why. The 
most commonly cited reasons for disregarding the guidelines included fear of litigation 
and that their patients were demanding a different interval. The authors summarized: 
“adherence rates are only moderate within a single health care maintenance organization 
and are likely even lower in the wider health care community” (Teoh et al., 2015, p. 8).  
An additional survey-based study, conducted in 2014 in Indiana, reflected similar 
concerns with guideline adherence. The survey used in this study was vignette-based, and 
findings indicated that providers were compliant with recommendations regarding when 
to start and stop screening. Non-compliance was found when looking at the 
recommended intervals for screening of those in the 21- to 65-year age range. In this 
study, only 18 (16.2%) of the 111 providers who responded appropriately followed the 
guidelines for all patient vignettes provided. In the 21- to 29-year age range 81% of 
providers responded with an incorrect screening interval, one that most closely aligned 
with the 1988 guidelines, out of date by 26 years at the time of this study. No correlation 
was found between age, gender, years in practice, and number of Pap smears performed 
per week and compliance with the guidelines. Reasons most commonly cited by 
providers in this survey for not adhering to the guidelines included concern for lack of 




The largest and most current survey-based study found during the review of the 
literature was conducted in 2016. Nearly 5,000 surveys were sent in California with 1,268 
respondents. Of these providers, 35% reported that they felt the guidelines were not 
clinically appropriate. Of those who did report finding the guidelines appropriate and that 
they were using them, only 15.3% were able to accurately recommend screening intervals 
for all patient scenarios given. This survey found that there were providers who were 
inappropriately screening women less than 21 years of age, over screening by frequency 
and use of HPV co-testing in the 21 to 30 age range, continuing co-testing every three 
years over the age of 30 when the recommendation is every five years, and 33% of 
providers reported continuing to screen those over the age of 65(Boone et al., 2016). 
In 2015, another survey-based study was conducted that aimed to evaluate the reasons 
behind poor guideline adherence. Concerns offered by survey respondents regarding less 
frequent screening, as recommended in the guidelines, were given. Thirty six percent of 
providers who were not following the guidelines named patient concern about the 
guidelines as their primary reason for not following. Other reasons given were health 
system quality measures that use different criteria, not agreeing with the guidelines, risk 
of malpractice, and inadequate time to have a risk versus benefit discussion with their 
patients regarding screening (Haas et al., 2015). 
In addition to research regarding provider adherence to the guidelines and reasons 
behind the poor adherence, the literature review discovered research regarding 
interventions to improve adherence. In Temple, Texas, at Baylor, Scott & White, a large 
primary care practice, a study assessed the impact of implementing both a provider 




cervical cancer screening guidelines was completed (Langsjoen et al., 2015). The aim of 
this study was to specifically look at compliance with ordering HPV co-testing for those 
over the age of 30. The authors found that their intervention had little effect on the 
practices of providers who specialized in gynecology but that they were already highly 
compliant with guidelines. For family practice providers, however, “Epic (the EHR) and 
a training session had minimal impact on compliance with ordering HPV cotesting at the 
time of a Pap smear except among family practice physicians, who did significantly 
improve their compliance rate” (Langsjoen et al., 2015, p. 453). 
The EHRs have supplied the opportunity for a new approach to increasing 
adherence with routine screening and care. This approach is in the form of point-of-care 
reminders for providers (Shojania et al., 2011). These point-of-care reminder systems are 
designed to help providers determine what their patients are due for during their visits 
and help to increase the likelihood that proper follow-up and screening are done. In a 
systematic review of electronic point-of-care reminder systems, it was determined that 
these reminder systems do show a moderate improvement in adherence to the process 
being studied (Shojania et al., 2011). While significant variability existed in the outcomes 
for the studies, a median increase of 4.2% was seen in overall process adherence with the 
addition of point-of-care reminders in the 28 studies included in the review (Shojania et 
al., 2011). The ability to utilize electronic reminder systems embedded into the EHR is 
one strategy that practices have implemented in order to give providers tools to adhere to 
best practice recommendations, including those surrounding cervical cancer screening.  
An additional study supports this finding that the use of the EHR over traditional 




quality of care. In 2011, a cross-sectional study was done to investigate the impact of 
implementation of an EHR on quality of care in four different health screenings.  
Physicians using EHRs provided significantly higher rates of recommended care 
than physicians using paper for four quality measures: hemoglobin A1c testing for 
patients with diabetes, breast cancer screening, chlamydia screening, and 
colorectal screening. (Kern, Barron, Dhopeshwarkar, Edwards, & Kaushal, 2012, 
p. 500) 
 
Per the updated guidelines, those under the age of 21 do not require cervical 
cancer screening. This is one population within the guidelines that has significantly lower 
adherence than others (Lozman, Belcher, & Sloand, 2013). A small quality improvement 
project was done at a pediatric primary care office. The intervention in this study was a 
30-minute educational session for all eight providers at the practice on the cervical cancer 
screening guidelines. Data analysis consisted of pre- and post-intervention chart reviews 
comparing adherence to the guidelines before and after the education. The number of 
unnecessary Pap tests done according to chart reviews in the six months prior to the 
intervention was 29. In the six months following the educational session, only two 
unnecessary Paps were done. “This small QI [quality improvement] project suggests that 
tailored educational sessions that allow for discussion may be beneficial in improving 
provider adherence to CPGs [clinical practice guidelines]” (Lozman et al., 2013, p. 586). 
Notification, Tracking and Reminder Systems 
 
The second part of the literature review focused on patient notification, tracking, 
and reminder systems. The same databases as mentioned above were searched using the 
terms test results notification, tracking and reminder systems, and patient notification. A 




were reviewed for this section and of those, eight were included in the final literature 
review. 
In addition to difficulty in determining appropriate screening intervals and follow-
up, providers and practices are faced with a need for a notification, tracking and reminder 
system that can manage the intricacies of clinical decision making and need for follow-up 
care that accompany cervical cancer screening. Patient notification of testing results is an 
important component of both quality and safety. In 2001, a report was prepared for the 
Agency for Healthcare Research and Quality (AHRQ) analyzing patient safety factors. 
One section of this report was in regard to critical results notifications, specifically 
notification of abnormal cervical cytology results. The study referenced in this section 
found that use of a form letter to notify patients was shown to decrease the amount of 
patients with cervical intraepithelial neoplasia lost to follow-up from 23% of patients lost 
to follow-up in the control group with standard notification practices to 0% lost to follow-
up in the group sent the form letter (University of California at San Fransisco (UCSF)—
Stanford University Evidence-based Practice Center, 2001). According to this AHRQ 
report, “One of the most distressing safety issues of the clinical encounter is the failure to 
follow- up on diagnostic tests, particularly when a patient is not notified of an abnormal 
result” (University of California at San Fransisco (UCSF)—Stanford University 
Evidence-based Practice Center, 2001, p. 482). This was the only study the AHRQ was 
able to find regarding patient notification of abnormal results that met inclusion criteria; 
however, despite the lack of strong evidence regarding notification systems, it remains 
necessary for practices to have systems for notification of test results. Additionally, in 




results and recommended follow-up (Slone et al., 2015). According to this study, as many 
as 35.3% of patients misunderstood their follow-up recommendations as verbally given to 
them by their provider. The EHR provides valuable tools in the realm of patient 
notification; however, provider and support staff comfort with the use of the EHR 
provide a limitation to its usefulness. 
The (electronic medical record) EMR shows great potential to assist health care 
providers in the areas of result interpretation, patient notification of test results, 
and documentation of the follow-up plan; however, there must be an 
understanding of the use. The clinician survey found lack of clinician confidence 
in using the EMR. Increased familiarity with the functions available for test 
results reporting in the EMR and increased use of these features could add 
standardization, efficiency, and confidence in the test results management 
process. (Sullivan & Smolowitz, 2013, p. 123) 
 
Recommendations for patient notification systems have been discussed; however, an 
important aspect of follow-up remains to be addressed. Practices and providers need a 
system to track patients and remind them to follow up at an appropriate interval based on 
findings of their cervical cancer screening. The American College of Obstetrics and 
Gynecologists (2012) published a committee opinion entitled, Tracking and Reminder 
Systems, that speaks to the concerns around failures that can occur in ineffective systems: 
Failure to follow up may cause delayed or missed diagnoses or treatment, which 
may result in an adverse patient outcome and potential liability for the health care 
provider. Failure to follow up on laboratory results has been identified as one of 
the leading causes of lawsuits in the outpatient setting. (p. 1) 
 
Electronic health records open the door to more efficient tracking systems than the pen 
and paper systems that existed prior to the wide spread use of EHRs. Researchers at the 
Boston University School of Medicine implemented a quality improvement process in 
which they embedded a patient tracking system into their EHR (Dupuis et al., 2010). 




diagnostic resolution of all abnormal results over a two-year period from 108 days to 86 
days (Dupuis et al., 2010). An additional study done at the University of Minnesota 
implemented a centralized tracking system for cervical cancer screening results. 
Following implementation of this EHR-based system, the system saw a 63.86% reduction 
in unnecessary Pap smears done in patients less than 21 years old (Teoh, Fall, 
Beitelspacher, & Lais, 2012).  
Despite the benefits of a patient tracking system embedded into the EHR, use of 
this tool continues to fail to realize its potential. A 2013 survey-based study found that 
less than half of the providers surveyed utilized the EHR to determine if patients had 
completed ordered tests. In this same study, 80% of providers reported that they were 
either not using the EHR to its full potential or were unsure about their use of the EHR 
and whether it could be utilized more extensively (Sullivan & Smolowitz, 2013). A 
reliable system for tracking and managing follow-up recommendations can serve to 
improve clinical outcomes and reduce liability for healthcare organizations (The 
American College of Obstetrics and Gynecologists, 2012). Furthermore, a 2016 study 
found that despite increased adoption of EHRs, system support for cervical cancer 
screening continued to be inadequate. This study found that only 16.4% of providers 
surveyed reported having an automated system in place to notify them of patients 
overdue for cervical cancer screening, and only 17.6% reported having a system in place 
to track follow-up after receipt of abnormal test results (Schapira et al., 2016). 
In addition to an accurate and reliable patient tracking system, practices need a 
process for reminding patients to follow-up at appropriate intervals. Accurate and timely 




recommendations (The American College of Obstetrics and Gynecologists, 2012). A 
2017 Kaiser Permanente study used focus groups to assess patient preferences in terms of 
follow-up reminders for cancer screenings. The researchers found that a personalized 
reminder letter, sent no more than three months prior to when the patient is due for 
screening, was preferred by the majority of study participants (Brandzel et al., 2017). 
Theoretical Framework 
The theoretical framework for this quality improvement project is Donabedian’s 
quality improvement model. This model was created by physician Avedis Donabedian 
and was first published in 1966 (Donabedian, 2005). Donabedian is widely renowned as 
the father of quality improvement in medicine as it is known today (Ayanian & Markel, 
2016). His work has been used to establish quality indicators for organizations such as 
the Institute of Medicine and is one of the most frequently cited works in the public 
health literature over the last 50 years (Dupuis et al., 2010). Donabedian (2005) provided 
a framework of three lenses through which evaluation of quality can be performed. This 
framework can be applied to the problem of cervical cancer screening guideline 
adherence and provider compliance in order to assess the opportunities for improvement 
and methods to address these. 
The first lens that Donabedian (2005) gave to view quality through was the lens of 
outcomes. Outcomes are a common way of assessing quality of care provided. They are 
generally concrete, are easy to validate, and can be measured. While Donabedian 
supported the power of outcomes as one method of assessing quality, he listed several 
limitations to this measure as well. Among these are the relevancy of chosen outcomes, 




length of time that needs to transpire before some outcomes can be evaluated. For the 
purpose of this project, the outcomes of following the evidence-based guidelines for 
screening are well substantiated and known to decrease mortality as a result of cervical 
cancer (Lees et al., 2016). Additionally, establishment of patient tracking and reminder 
systems have shown to increase patient compliance with follow-up recommendations 
(The American College of Obstetrics and Gynecologists, 2012). Furthermore, the time 
frames associated with follow-up for cervical cytology restrict the feasibility of 
evaluating patient follow-up for this project. With widespread agreement on the effect of 
timely evidence-based screening with appropriate follow-up, patient outcomes will not be 
evaluated in this project.  
The second lens that Donabedian (2005) spoke to was to evaluate the process of 
how care is provided. On evaluation of process, Donabedian stated: “One is interested not 
in the power of medical technology to achieve results, but in whether what is known to be 
‘good’ medical care has been applied” (p. 694). This arm of quality evaluation looks at 
the provider’s skill and knowledge, completeness of the physical examination, 
appropriateness of further evaluation decisions, provision of appropriate preventative 
care, among other factors (Donabedian, 2005). The process evaluation for this project 
revealed a need for assessment of the provider’s knowledge and practice gaps and an 
educational strategy aimed at addressing these.  
The final lens that Donabedian (2005) gave was the lens of structure. Structure 
evaluation includes reviewing the administrative, facility, and equipment factors that 
affect quality. The implementation of the notification, tracking and reminder system is 




convenient system for managing follow-up communication and reminders aimed at 
increasing patient follow-up compliance and reducing liability of the organization 















Following the review of the literature and an analysis of the current state, the 
project plan was established. The following chapter is a review of the project plan 
including the project objectives and evaluation plan, resources needed, a timeline, and an 
analysis of the congruence of the project plan with the organization’s objectives. The 
project plan is divided into two phases. (see Appendix C for an infographic of the project 
plan). 
Phase One 
Phase One focused on the preparation for Go Live for the patient notification, 
tracking and reminder system and gathering of pre-implementation data. A survey was 
distributed to providers to assess perceived barriers to adherence as well as current 
knowledge regarding the American Society for Colposcopy and Cervical Pathology 
(ASCCP) guidelines (see Appendix D for a sample survey). This survey was modified 
from a survey created jointly by the Agency for Healthcare Research and Quality 
(AHRQ), National Cancer Institute, and Centers for Disease Control: “National Survey of 
Primary Care Physicians’ Cancer Screening Recommendations and Practices” (National 
Cancer Institute, 2006). The breast cancer screening questions were removed, and clinical 
vignettes were updated to reflect changes in the guidelines since the survey’s creation in 




information and the structure and process components not addressed in the survey in its 
original form. This survey has been modified several times by the named agency to make 
it applicable to a variety of cancer screenings, thus further information regarding the 
validity of the tool was not available (National Cancer Institute, 2006). The survey was 
reviewed by the Doctor of Nursing Practice (DNP) project chair, physician chair on the 
project committee, and medical director of the practice prior to distribution.  
The modified survey contained 18 total questions and was divided into three 
sections. Question types included multiple-choice, select all that apply, Likert scales, and 
free text. Section A contained demographic data about the respondent. This demographic 
data included information such as the provider’s age, gender, years in practice, 
credentials, approximate number of patients, percentage of those patients who are female, 
and average number of patients screened for cervical cancer annually. Questions in this 
section included four multiple-choice questions and two free text questions. This 
information was used in aggregate form for data analysis and trending.  
Section B focused on evaluation of the process components of this project. 
Questions were in regard to the provider’s current guideline preference, trust in the 
evidence behind the guidelines, a series of patient vignettes in which the provider 
indicated what the initial screening and recommended follow-up would be, and a 
question regarding possible barriers to guideline adherence. One question had a Likert 
scale response. Three questions were in a multiple-choice format. One question was a 
select all that apply. 
Section C focused on the structure component of the project and included whether 




provider reminders when screening is due, patient reminders when screening is due, and a 
tracking system to identify patients who have not followed up as recommended. There 
was also a question regarding whether the provider used any resources to assist in 
determining follow-up recommendations based on the guidelines. Four of these questions 
were in a select all that apply format and one question was multiple-choice. Finally, there 
was a free text section that allowed the provider to add any additional information about 
cervical cancer screening that they felt was important.  
The pre-implementation survey had 12 respondents of the total 48, for a 25% rate. 
The post-implementation survey had 10 respondents of the total 35 eligible providers, for 
a response rate of 28.5%. Upon receipt of the survey results, the responses were 
evaluated to determine the current state of knowledge and compliance barriers at the 
practice. An evidence-based presentation was then presented giving the history of, and 
evidence behind, the guidelines as well as methods and resources for addressing any 
identified barriers to guideline adherence. This presentation was customized based on the 
survey results in order to best address the barriers to guideline adherence at this practice. 
The provider educational session aimed to address the process component of this quality 
improvement project (Donabedian, 2005) (see Appendix E for an outline of the 
educational session). 
Additionally, during this phase of the project, the final planning and creation of 
training materials for the patient tracking and reminder system was completed that 
worked to address the structure component of the quality improvement project 
(Donabedian, 2005). The author worked with the electronic health record (EHR) 




notification, tracking, and reminder system. A group of nurse leaders in the organization 
was chosen to pilot managing the notification, tracking and reminder system and formed 
what was referred to as the Pap pool.  
These nurse leaders served as advisors during the creation of this process as well. 
The existing reminder system, as well as the point-of-care reminder system that was 
available in the EHR, was utilized for this process. Letter templates and templated 
phrases were created during this phase and were embedded into the EHR for an efficient 
process of notifying and reminding patients. Training was also provided to the nurses and 
support staff who managed the Pap pool.  
The final process that was created involved the provider indicating the findings 
and the recommended follow-up and routing this note to the Pap pool in the EHR. The 
Pap pool nurses who managed the pool then took the result note and notified the patient. 
All abnormal results notifications occurred verbally by telephone, followed by a form 
letter sent through either the patient portal or by mail. Literature on patient notifications 
has identified that patients are more likely to misunderstand follow-up reccomendations 
when given verbally and that the use of a form letter has been found to increase patient 
compliance with the recommendations (Slone et al., 2015; University of California at San 
Fransisco (UCSF)—Stanford University Evidence-based Practice Center, 2001). Patient 
notification letters were created using plain language definitions of the cervical cancer 
screening findings as well as the reccomended follow-up and instructions for the patient 





Following notification of the patient, the Pap pool nurse then updated a report in 
the EHR called the Pap track report. This action updated the point-of-care reminder 
system embedded into the EHR. The nurse then placed a “tickler,” an electronic reminder 
embedded into the EHR, for the Pap pool that would alert the month that the patient is 
due to repeat their screening. In the future, when this tickler alerts the Pap pool nurse, the 
nurs will then check the patient’s chart to identify if she hase completed or scheduled a 
follow-up screening. If she has, the chart is closed out. If she has not, the Pap pool nurse 
will send the patient a reminder letter to follow-up and set another tickler for a month out. 
This reminder letter will be sent no more than a month prior to the reccomended follow-
up, as this time frame was found in the evidence to be the most effective (Brandzel et al., 
2017). A second, and then third and final, reminder letter are then sent using the same 
process before the chart is closed out.  
Phase Two 
During this phase, the presentation was presented to practice providers. This 
presentation included education on the history of the guidelines and evidence supporting 
their implementation as well as training on the use of the patient tracking and reminder 
system and available EHR support and tools. (see Appendix E for an outline of the 
educational session). Additionally, training for the nursing and support staff was 
completed. Each clinic received the educational session and then began utilizing the new 
process immediately after completion of this session. 
Following implementation of these interventions, patient charts were monitored 
for guideline adherence using the chart audit form that can be found in Appendix F. The 




first section evaluated guideline adherence, and the second evaluated process adherence 
with the new notification, tracking and reminder system. The initial pre-implementation 
survey was again sent to the providers as a posttest to identify any change in perceived 
barriers and any change to knowledge of proper follow-up and management using the 
vignette scenarios.  
Objectives 
For this DNP project, the following objectives were planned: Objective One, 
improve provider adherence to the 2012 ASCCP guidelines and Objective Two, 
implement and evaluate an electronic patient notification, tracking and reminder system.  
Objective One: Improve Provider 
Adherence to the 2012 American 
Society for Colposcopy and 
Cervical Pathology 
Guidelines 
This objective was evaluated through two different data sources. The first was 
through analysis of pre- and post-implementation surveys. The survey questions that were 
used for evaluation of this objective were B1-5 and C3. Descriptive statistics were used 
including age ranges, provider characteristics, and patient populations seen. These were 
compared to overall guideline compliance to evaluate for any potential trends. The 
question with the Likert scale response was evaluated and pre- and post-intervention 
results were compared to determine impact. The patient scenarios were marked as correct 
or incorrect based on the 2012 ASCCP recommendations and were expressed as the 
percent correct and compared pre- and post-intervention. Any selections that met either 
the recommended or acceptable responses as stated by the ASCCP guidelines were 




regarding primary human papillomavirus (HPV) testing, these were marked as correct as 
well (ASCCP, 2014). Question B5 regarding perceived barriers was analyzed by 
percentage of providers who responded indicating each given option as a barrier to 
implementation and was again compared pre- and post-intervention. Due to limited 
sample size for the survey, parametric data analysis was not feasible. The Mann Whitney 
U test was used to account for the small sample size in order to compare pre- and post-
intervention changes.  
The second source of data was in the form of chart reviews (see Appendix D for 
sample chart review form). A report was run on all patients who had cervical pathology 
results during the six months leading up to implementation and following implementation 
until the end of the data collection period. A representative 20% were reviewed to 
determine whether the follow-up was congruent with the 2012 ASCCP recommendations. 
Questions 1 and 2 were expressed in terms of percentage correct out of the charts 
reviewed and were again compared pre and post intervention. As there was a larger 
sample size for chart audits, the two-tailed t-test was used to evaluate pre- and post-
intervention findings. 
Objective Two: Implement an 
Electronic Patient Notification, 
Tracking and Reminder 
System 
 
 This objective was evaluated using chart audits (see Appendix F) and the survey 
as well. To evaluate this, the researcher reviewed charts for adherence to the 
implemented process. In order to assess the impact of this quality improvement project, 
pre- and post-survey responses were also evaluated that looked at barriers to guideline 




and post-implementation in order to evaluate effectiveness of the quality improvement 
project from the provider’s perspective. These questions were evaluated in terms of 
percentage of providers who indicated in the affirmative that there is a process in place 
for each question. Again, the Mann Whitney U test was used to compare pre- and post-
data to account for the low sample size. For the chart audits for this section, there is not 
comparison data for this as this is a new process that is being evaluated. Data are 
presented in terms of overall adherence with the process. Questions 3 through 5 are 
expressed in percentages that are completed correctly in accordance with the new 
process. 
Congruence with Organization Objectives 
The study site was a primary care clinic with multiple office locations in northern 
Colorado that was founded in the 1960s. It is structured as a patient-centered medical 
home and accepts multiple private insurances as well as Medicare and Medicaid. As a 
patient-centered medical home, the practice proposes that their care emphasizes 
improving and maintaining healthy lifestyles through evidence-based care. Objective 
One, regarding improving provider compliance with the 2012 ASCCP guidelines, aligns 
closely with this statement. The guidelines are evidence-based and proper management of 
cervical cancer screening helps patients strive to maintain health. The practice also 
focuses on the experience of the patient seeking care there and in ensuring consistent and 
thorough communication occurs. Objective Two, which focuses on the patient 
notification, tracking and reminder system, aligns well with the practice’s strategy of 
providing peace of mind to patients by ensuring that communication regarding their 




Timeline of Project Phases 
The project proposal was approved in early spring 2018. Following successful 
defense of the proposal and the University of Northern Colorado’s Institutional Review 
Board approval (see Appendix G), the survey was distributed to providers in November 
2018. The initial survey was given to providers with a two-week window given for 
responses. At the completion of the survey cycle, the results were reviewed, and 
information on evidence-based screening guidelines and available resources was 
presented to practice providers using the survey results to identify areas of focus for the 
quality improvement project and educational session. Two weeks following the 
presentation, the same survey was sent again to providers for post-implementation 
evaluation purposes.  
During this timeframe, training materials were created for providers and nursing 
staff. Additionally, EHR modifications were made including building dot phrases, letter 
templates, and creation of an electronic nurse pool entitled the cervical cancer screening 
pool, referred to in this project as the Pap pool. Following the creation of these materials, 
training was provided to nursing staff during leadership meetings. Additionally, each 
clinic received an educational session over the lunch hour for providers. After each office 
received the provider educational session, the process went live. Following the Go Live 
at each clinic, chart audits occurred. A 20% representative population of all patients with 
cervical cytology ordered was audited in order to measure compliance with both the 





As this project focused on using resources that already existed within the system, 
the resource need was low. The largest resource was the time to train staff and for their 
participation in the project. The approximate time for training on the notification, 
tracking and reminder system was one hour for the nurses at the clinics. The nurse 
managers also met with the researchers for a total of approximately four hours to discuss 
creation of the new process. The time expense for providers was a one-hour educational 
and training session in addition to an estimated 30 minutes to answer both the pre- and 
post-survey.  
Other resources needed were support of stakeholders. These included the 
practice’s medical director, nursing support staff, and the electronic health record 
specialist. Additionally, there was a limited cost for copying and handouts to be provided 
to the support staff and providers. Most clinics chose to provide lunch for the provider 
educational session as well. The final resource needed was the time of the researcher as 
well as travel back and forth to the clinical sites. 
Ethical Considerations 
 In order to protect study participants, Institutional Review Board approval was 
obtained prior to beginning any research. The largest ethical consideration with this 
project was protecting the anonymity of the providers participating in the survey. Survey 
participation was voluntary, and there were no repercussions for choosing not to 
participate. An introduction letter (see Appendix H) and consent form were sent with 
each communication regarding the survey informing participants of the purpose of the 




be withdrawn at any time. The practice medical director distributed the survey link via e-
mail. All information provided in the surveys was presented in aggregate form and 
contained no identifying information for the provider. All data collected from chart audits 
were free of identifying information for both patients and providers, and no patient 
information was stored externally outside of the EHR. 
Statement of Mutual Agreement 
The statement of mutual agreement designates the agreement between the practice 













RESULTS AND OUTCOMES 
 
Following Phase I and II of the project, data collection was completed in order to 
evaluate the effectiveness of the project plan related to the objectives identified. There 
were two sources of data utilized for review: the provider survey and retrospective chart 
audits. The chapter presents an analysis of the results and outcomes for each project 
objective. 
The pre-implementation survey was sent to the entire practice and had 12 
respondents of the total 48 included providers for a response rate of 25%. Two providers 
partially completed the survey. The partial responses were included in the data presented 
up through the questions that were completed. The post-implementation survey was sent 
to a representative group of six of the total nine clinics that had gone live at the time of 
data collection. The post-implementation survey had 10 respondents of the total 35 
included for a response rate of 28.57%. Refer to Table 1 for demographic data of both 
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Note. MD/DO = medical doctor/doctor of osteopathic medicine; PA = physician 




Additionally, providers were asked about the populations of patients they see 
including age, gender, and volume of screening they complete annually. For age of the 
patient, the providers were given the options of under 18, 18 to 39, 40 to 64, and > 65 and 
asked to estimate the percentage of patients in each age category that they see in practice. 




intervention responses, on average, 61.5% of patients seen by the providers were female 
and post-intervention, 58.7% were female. Question 7 was in regard to the frequency that 
cervical cancer screening was done by provider. Pre-implementation, one provider (8%), 
indicated doing only one to 10 screenings annually. Two (17%) indicated that they do 11 
to 20 screenings annually. The remaining nine (75%) indicated that they do > 20 
screenings per year. The post-intervention survey indicated that the providers who 
responded all completed > 20 screenings per year except one who indicated doing 11 to 
20 screenings annually.  
 
Table 2 
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 19.17 5.34 
 
 25.42 5.19 
 
 30.83 8.37 
 
 22.92 10.30 
 
 19 4.96 
 
 28.13 14.38 
 
 30.63 10.5 
 
 21.88 12.8 
 
 
The two survey distributions had similar response rates. Overall demographics 
were similar as well. The post-intervention survey had a higher percentage of doctors 
who responded and less Physician Assistants than the pre-intervention. There was also a 




versus the pre-intervention survey with an equal distribution in all age categories. Post-
intervention, survey respondents were equally divided with 50% being male and 50% 
being female. The pre-intervention survey had a higher (75%) proportion of male 
respondents to females (25%). Finally, the distribution for years in practice remained 
with the highest percentage being > 10 pre- and post- intervention (67% and 60%, 
respectively). The pre-intervention survey had no respondents in the 5 to 10-year range of 
years of practice whereas the post-intervention survey had two. For patient populations 
seen, the post-intervention group was very similar to the pre-intervention group for both 
patient age and overall percentage of female patients seen.  
The second method of data collection, chart audits, was completed on a 
representative 20% of total charts for patients who had cervical cancer screening 
completed during the time frame. Pre-implementation audits were collected from June 1, 
2018, to December 1, 2018. Post-implementation audits were done following completion 
of the roll out at a representative six of the total nine clinics in February 2019 through 
March 11, 2019. 
Objective One: Improve Provider Adherence to 
the 2012 American Society of Colposcopy and 
Cervical Pathology Guidelines 
 
Provider Survey 
For Objective One, questions B1 through B5 and C3 were evaluated.  
B1. How effective do you believe the following screening procedures are in 
reducing cervical cancer mortality in average-risk women? For each of the following 
options, Pap test alone, human papillomavirus (HPV) genotyping with Pap test, and HPV 




perceived efficacy using the Likert scale options of very effective, somewhat effective, 
not effective, and effectiveness not known.  
Both pre- and post- intervention surveys indicated that providers, on average, felt 
most confident with Pap testing with HPV co-testing. This is the testing most supported 
by the guidelines. In the pre-intervention survey, 83.33% of providers indicated that they 
felt this method of screening was very effective and, following the educational session, 
100% of providers chose this option.  
The guidelines also give options for primary HPV screening. A brief discussion of 
the evidence supporting this recommendation was given in the provider educational 
session. The pre-intervention survey indicated that five providers (41.67%) believe this 
method of screening to be very effective, three (25%) indicated that they believe it is 
somewhat effective, two (16.67%) indicated that they believe that it is not effective, and 
the final two (16.67%) indicated that they did not feel the efficacy of this method of 
screening was known. Following the educational session, 60% of providers responded 
that they believe primary HPV testing to be very effective, and 40% responded that they 
believe it to be somewhat effective. No providers chose the not effective or effectiveness 
not known options.  
B2. In your clinical practice which cervical cancer screening guidelines do 
you follow? The majority of the providers, eight (66.67%), selected that they were 
following the American Society of Colposcopy and Cervical Pathology (ASCCP) 
guidelines, while two (16.67%) indicated that they were following the United States 
Preventative Task Force Services guidelines. The final two (16.67%) indicated that they 




Following the educational session, seven providers (87.5%) indicated that they were 
following the ASCCP guidelines. One provider (12.5%) indicated following the United 
States Preventative Task Force Services guidelines. Two did not respond to this question.  
B3. Assume that the following asymptomatic female patients present for a 
routine visit in your office. What would you be most likely to recommend for 
cervical cancer screening at this visit? Respondents were asked to identify screening 
procedure and interval. Screening procedure options: Pap, Pap + HPV testing, HPV 
testing alone, none, and other: (comment). Follow-up interval options: annually, every 
three years, every five years, none, and other: (comment). See Table 3 for survey findings 
for this question.  
The following scenarios are from the survey: 
A. An 18-year-old who had sexual intercourse for the first time one month 
ago and is presenting for her first gynecologic visit: For this vignette, the correct answers 
would be none for both the screening procedure and interval, as this patient should not be 
screened for cervical cancer due to being under the age of 21.  
B. An 18-year-old who first had sexual intercourse three years ago and is 
presenting for her first gynecologic visit: For this vignette, the correct answers would be 
none for both the screening procedure and interval as well for the same reason listed 
above.  
C. A 21-year-old who has received the entire HPV vaccine series: The correct 
answers for this vignette are cervical cytology and every three years. Current guidelines 




D. A 25-year-old who has no history of abnormal Pap smears: The correct 
answer for this vignette is also cervical cytology every three years.  
E. A 35-year-old who has had three consecutive negative Pap tests performed 
by you: The correct answer for this vignette is co-testing (Pap and HPV testing) every 
five years.  
F. A 35-year-old whose cervix was removed last year during hysterectomy 
for symptomatic fibroids: The correct answer for this question would be none for both 
screening test and interval as this patient has had a hysterectomy with removal of the 
cervix for a non-cancer related reason. 
G. A healthy 66-year-old who has had three consecutive negative Pap tests 
performed by you; the last was a co-test three years ago which was negative for HPV as 
well: The correct answer for this vignette is none as screening recommendations are that 
screening complete at age 65.  
H. A healthy 66-year-old who has not had routine screening for cervical 
cancer since her mid-30s: This question was excluded from data analysis and from the 
post-intervention survey as it did not contain the necessary option of once for the follow-
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B4. You receive the following results on the following patients. What is your 
follow-up recommendation? Respondents were asked to indicate their recommended 
follow-up procedure and interval. Procedure options: repeat Pap cytology, reflex HPV 
testing, Pap + HPV testing, colposcopy, and other: (comment). Interval options: 
immediate, one year, every three years, and every five years. 
The following scenarios are from the survey: 
A. A 21-year-old with result of atypical squamous cells of undetermined 
significance (ASC-US) with no prior screening. The acceptable answers for this vignette 




B. A 22-year-old with results of low-grade squamous intraepithelial lesion 
with no prior screening. The acceptable answer for this question was a repeat Pap test in 
one year. The reflex HPV test is indicated by the guidelines to be acceptable for ASC-US 
only.  
C. A 25-year-old with result of ASC-US with prior negative Pap. There were 
two acceptable options for this vignette: reflex HPV immediately or repeat Pap cytology 
in one year.  
D. A 31-year-old with result of negative cytology and HPV, prior result low-
grade squamous intraepithelial lesion. This question was excluded from data analysis and 
the post-intervention survey as the vignette did not provide the necessary information to 
indicate follow-up recommendation. 
E. A 35-year-old with negative cytology but positive HPV test: HPV 16 and 
18 negative. The correct follow-up for this vignette was co-testing (Pap and HPV) in one 
year. 
F. A 38-year-old with low-grade squamous intraepithelial lesion and negative 
HPV test. The acceptable options for this vignette are immediate colposcopy or repeat co-
testing at one year.  
G. A 42-year-old with a result of ASC-US and HPV negative, prior result 
cytology negative, HPV positive. The correct follow-up for this vignette would be 
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B5. Are you following current screening guidelines on all of your patients? If 
no, why not? Options: yes, I am following current screening guidelines; no, I do not 
know the current guidelines; no, I do not think guidelines are based on good data; no, I 
believe I have a higher-risk population; no, my patients are requesting more frequent 
screening; no, I am worried about missing high grade dysplasia or cancer in the interim; 
and no, I am worried about being able to keep track of whether my patients complete 
follow-up with a longer screening interval. 
Prior to the implementation of the project, eight (72.73%) of the providers who 
responded indicated that they are following the current guidelines. One provider (9.09%) 
indicated patient preference as their reason for not following the guidelines. One provider 




of five but did not indicate why. Following the educational session, nine (90%) of 
providers indicated that they were following the guidelines. One provider indicated other 
and were following the guidelines except not recommending co-testing every three years 
in most women. 
C3. Do you use any of the following resources for managing cervical cancer 
screening in practice? Options given: printed guidelines, website, phone or tablet 
application, patient handouts, other: (comment), or none of the above. 
Prior to the intervention, nine providers (90%) indicated that they were using a 
resource of some sort in practice. One provider indicated using printed guidelines, two 
(18.18%) indicated that they use the ASCCP website, and six (54.55%) indicated that 
they use the phone or tablet application created by the ASCCP. One provider indicated 
that not using any resources. One provider did not answer this question. Post intervention, 
all providers indicated that they were using a resource of some sort in clinical practice. 
Six providers indicated that they were using the ASCCP application. Two providers 
indicated that they were using the website. One provider indicated using patient handouts. 
The final provider indicated using patient handouts, printed guidelines, and a reminder 





For Objective One, chart audits were done comparing guideline compliance pre- 
and post-intervention. A report was run to identify all clinic patients who had cervical 
cytology ordered during the above mentioned six months preceding the project 
implementation and following the educational session at each clinic until the completion 
of the project in March 2019. For the initial, pre-intervention chart audits, there were a 
total of 2,121 patients who had cervical cytology performed during the six-month 
window. Of these, a representative 20% of the charts were audited for a total of 425. 
Post-intervention, there were a total of 232 charts that met inclusion criteria, resulting in a 
20% representative sample of 47 charts that were included in the auditing process. An 
independent t-test was used to compare the pre- and post-intervention findings. 
Question one: Did recommended follow-up comply with either the preferred 
or acceptable options per the 2012 American Society of Colposcopy and Cervical 
Pathology guidelines? For Question one, the provider’s result note in the chart was used 
for the audit as well as the results of cytology and prior results, if available. The patient’s 
information was input into the ASCCP tablet application, and the appropriate follow-up 
was identified using all available information recorded in the patient’s chart for accuracy. 
This follow-up was compared to the follow-up indicated by the provider in the result 
note. The result note is completed by the provider after receiving the results indicating 
that they received the results, reviewed them, and anything they would like done with the 
results such as patient notification and follow-up. If the provider used either the preferred 
or acceptable recommendations from the 2012 ASCCP guidelines or used primary HPV 




was considered in alignment with the guidelines. Additionally, if the provider mentioned 
that the patient was following a different interval due to another health condition, such as 
immunocompromise, these charts were excluded from the audit. Each chart audited was 
marked as either a yes, no, or not indicated. A yes indicated that the provider 
recommended a follow-up interval and procedure that was in alignment with the 
guidelines as indicated above. A no indicated that the recommended follow-up was not in 
alignment with the guidelines, either by interval or procedure. A not indicated was used 
when the provider did not indicate when or how the patient should follow up in their 
result note. A two-tailed t-test was used to evaluate the pre- and post-intervention data for 






























































Question two: If available, did screening interval from last screening comply 
with the 2012 American Society of Colposcopy and Cervical Pathology guidelines? 
For Question two, a complete review of the necessary aspects of the chart was completed 
to gather all historical information electronically available. This included the provider’s 
note, past pathology results, and past result notes. This information was input into the 
ASCCP tablet application to identify the recommended follow-up based on all 
information available for the most recent prior available screening result. If the current 
screening occurred less than 12 months either before or after the recommended follow-up 
time frame, the chart audit form was recorded with a yes. If the time frame fell outside of 
the 12-month allowance on either side of the recommended follow-up interval, a no was 
recorded. A no was also recorded if a different type of testing or procedure was done than 
what the guidelines recommended. This included use of HPV testing outside of what the 
guidelines recommend. If the information available was insufficient to identify when the 
patient was due for re-screening or re-testing, an unknown response was recorded. A two-




































































Objective Two: Implement and Evaluate an Electronic 
Patient Notification, Tracking and Reminder System 
 
Provider Survey 
For Objective two, questions of C1, C2, C4, and C5 and were evaluated. 
C1. Does your practice have a mechanism to remind you or other members of 
the care team that a patient is due for cervical cancer screening? Options given: yes, 
special notation of flag in patient’s chart; yes, computer prompt or computer-generated 
flow sheet; yes, I routinely look it up in the medical record at the time of a visit, yes, 
other mechanism (specify), and no. 
Pre-intervention, 10 providers responded to this question. Of those, six (60%) 
indicated that there was a provider reminder system in place. No providers selected the 
option of special notation of flag in the patient’s chart. Two (20%) selected computer 
prompt or computer-generated flow sheet. Four (40%) providers indicated that they 




indicated that there is a file system in place. Finally, three providers (30%) indicated that 
there was no mechanism in place. Two providers did not answer this question. 
On the post-intervention survey, all 10 providers indicated that there was a 
mechanism to remind them that patients are due for screening. Eight providers (80%) 
indicated that they use a chart review to identify what the patient was due for. Four 
providers (40%) also indicated that there was an EHR point-of-care reminder of some 
sort in their response.   
C2. Does your practice have a mechanism to remind your patients that they 
are due for cervical cancer screening? Options given: yes, verbal prompt from you or 
another member of the care team during an office visit, yes, reminder by mail, yes, 
reminder telephone call, yes, reminder by e-mail, yes, other mechanism (specify), no, and 
I don’t know. 
Prior to project implementation, four providers (40%) indicated that there was 
some form of patient reminder system in place including telephone calls, e-mails, and 
mailed notification. No providers selected the verbal prompt option. Three providers 
(30%) indicated no, and one provider (10%) indicated I don’t know. Two providers did 
not answer this question. 
Post-implementation, seven providers (70%) indicated that there was a patient 
reminder system in place. Options chosen included mailed reminders, patient portal 
message, telephone call, and e-mail, all of which were included in the new reminder 
process. One provider (10%) indicated that there was not a notification system in place, 




C4. Does your practice have a system to track patients who do not complete 
follow-up of an abnormal screening result? Options given: yes and no. 
For the pre-intervention survey results, six providers (60%) responded yes, two 
providers (20%) responded no, and two providers (20%) responded I don’t know. Two 
providers did not respond to this question. Following roll out of the new system, nine 
providers (90%) indicated that there was a tracking system in place, and one provider 
(10%) indicated that there was not. 
C5. Does your practice have a mechanism to inform patients of abnormal 
results? Options given: yes, letter by mail; yes, telephone call; yes, e-mail message; yes, 
other method (specify); I don’t know; and no. 
Prior to the roll out of the new system, all providers indicated that there was a 
notification system in place and that this notification occurred via a telephone call. One 
provider indicated that patient’s may also receive e-mail notification of results. One 
provider selected the other option and wrote in that a letter is sent if the patient does not 
answer their message. Two providers did not respond to this question. Following roll out, 
all providers again indicated that there was a notification system in place. On this survey, 
however, more options were chosen for how patients were notified included a telephone 
call, e-mail, and mailed notification.   
Chart Audits 
For the chart audits for this section, there is not comparison data for this as this 
was a new process that is being evaluated. Data were evaluated in terms of overall 
adherence with the process. Questions three through five were expressed as percentages 




Question one: Was a result note placed and routed to the cervical cancer screening 
pool? 
Question two: Was a tickler placed in the patient’s system? 
Question three: Was a notification letter sent to the patient? 
For all three questions, nursing compliance with the process was found to be 
100%. If the provider placed the result note and routed it to the Pap pool, Questions two 
and three in regard to the tickler and notification system were found to have been done 
appropriately. For provider compliance with the new process, Question one, 12 of the 
charts (26%) were done incorrectly and 35 of the charts (74%) were done correctly. For 












RECCOMENDATIONS AND IMPLICATIONS 
FOR PRACTICE 
 
 The purpose of this quality improvement project was to improve provider 
guideline adherence through an educational system implemented alongside an updated, 
evidence based notification, tracking and reminder system. Following implementation of 
this project and collection of pre- and post-data, the results were evaluated to determine 
the impact of the project. The following chapter serves to outline the researcher’s 
recommendations and implications for practice following completion of this project. 
Analysis of Findings 
Objective One 
The quality improvement project included data collection through two sources: 
provider surveys and chart audits. For Objective One, the data collected were analyzed to 
identify any trends found in provider practice as well as to identify the effectiveness of 
the educational session and new cervical cancer screening management process for the 
clinic in improving provider compliance with the American Society for Colposcopy and 
Cervical Pathology (ASCCP) guidelines.  
The first portion of analysis served to determine if a difference was found in 
provider compliance by different demographic factors. There was no statistical difference 
in guideline compliance for identification of appropriate screening scenarios and follow-




including gender of provider, type of provider, age of provider, years in practice, 
percentage of female patients seen, age populations seen, or number of screenings 
performed annually. 
The second portion of data analysis for the survey compared pre- and post- 
intervention findings in the context of Objective One. A shift in provider’s attitudes 
towards cervical cancer screening practices was identified. Providers were 16.67% more 
likely to indicate that they felt the use of human papillomavirus (HPV) testing in 
conjunction with Pap testing was very effective in screening for cervical cancer. They 
were also 18.33% more likely to indicate very effective when referring to primary HPV 
testing, a method of screening that has strong support in the evidence but has not been 
adopted widespread in practice as of yet (ASCCP, 2014). Providers were also 20.83% 
more likely to indicate that they were following the ASCCP guidelines as opposed to 
other guidelines that exist. 
For the pre-intervention survey, 83.33% of providers were able to correctly 
identify the routine screening recommendations (Survey Question B3) for all patient 
scenarios given as compared to 100% of providers on the post-intervention survey. A 
16.67% improvement was found in providers’ abilities to identify the correct screening 
interval following the intervention. Additionally, Question B4 was used to evaluate the 
provider’s guideline adherence when indicating the suggested follow-up based on the 
cervical cancer screening findings. Pre-intervention, none of the providers were able to 
accurately recommend follow-up according to the guidelines for all scenarios. Following 
the intervention, three providers were able to correctly identify the follow-up for all of 




means that the Mann-Whitney U value for all data analysis exceeded that of the critical 
value, meaning the researcher is unable to reject the null hypothesis based on the findings 
from the research. This limits the ability of the researcher to make assumptions about the 
statistical accuracy of these results.  
The second source of data for the project was the chart reviews. The two 
questions used in the chart review evaluated this objective according to both how the 
providers indicated that they would practice as well as how that knowledge translated 
into practice. Comparison of both sources of data found that this quality improvement 
project did show a statistically significant improvement in how providers indicated that 
they would practice and recommended follow-up screening but did not show a statistical 
difference in how frequently they actually performed that follow-up.  
Following the educational session and Go Live of the Pap track process, providers 
were twice as likely (p = 0.0176) to have indicated what the recommended follow-up 
should be in their result note following receipt of the cervical cancer screening pathology 
and laboratory results. Additionally, providers were 31.63% (p < 0.0001) more likely to 
not only have indicated when the patient should follow-up, but to have adhered to the 
ASCCP guidelines in indicating their recommended follow-up. 
While these results show a significant improvement in follow-up 
recommendations made, there was found to be no statistical difference in whether the 
screening performed by the provider at the current visit complied with the guidelines or 
not following implementation of the project. Both pre- and post-intervention, over one-
third of patients had screening done that was either too early, too late, or an inappropriate 




recommend that their patients follow up appropriately but were no more likely to actually 
complete the screening according to the guidelines.  
These findings align with research findings in the literature review. Prior to the 
quality improvement project, 25% of the time the recommended follow-up on the 
cervical cancer screening result was incorrect. No providers were able to correctly 
identify the appropriate screening interval and appropriate follow-up for all of the 
scenarios given as well. This aligns closely with findings in the literature of poor overall 
guideline adherence. Research utilizing educational sessions for providers as well as use 
of point-of-care reminders in the electronic health record (EHR) were found to have 
shown a moderate improvement in guideline adherence (Langsjoen et al., 2015; Lozman 
et al., 2013). This quality improvement project did not find this to be the case. It was not 
possible within the scope of this project to evaluate the impact of the reminders that were 
embedded into the EHR as these point-of-care reminders will not be utilized until the 
next time the patient is due for screening. Following the educational session, there was 
found to be a statistically significant improvement in guideline adherence for 
recommended follow-up following receipt of screening results. While this finding 
supports that the educational session and new system improved provider compliance with 
the recommendations, this did not hold true for how the providers practiced before and 
after the intervention. They were more likely to recommend appropriate follow-up; 
however, they continued to screen either too early or too late according to the guidelines.  
Facilitators. The medical director and quality director served as facilitators for 
this objective. They assisted the researcher in developing educational materials as well as 




each clinic assisted in scheduling, setting up, and providing lunch for the educational 
sessions at each clinic. Another facilitator for this objective included the level of 
engagement of the providers at the practice. During the educational sessions, many 
providers expressed excitement and support of the new process as well as with closer 
adherence to the evidence-based guidelines. Finally, the availability of a robust EHR 
system, as well as an EHR specialist to assist with the project and report build in order to 
complete chart audits, were significant facilitators in evaluating objective one.  
Barriers. Limitations to the data collection for evaluation of Objective one did 
exist. The primary limitation is the small sample size for the survey response. This small 
sample size limits the data analysis that can be done and the inferences that can be made 
based off of that analysis. In order to prevent identification of providers who completed 
the survey, survey responses were presented in aggregate form and did not include 
identifying information. This limited the analysis of the data by making it impossible to 
compare pre- and post-survey findings of the same provider. Also, there was no way of 
identifying whether providers who responded on the post-intervention survey had 
actually attended the educational session. 
Additionally, provider comments in the survey indicated a lack of understanding 
of some of the questions such as references to annual pelvic exams and sexual transmitted 
disease screening when being asked about cervical cancer screening. Some providers 
partially answered the screening and follow-up questions by answering what the follow-
up should be but not the interval that it should be done in. In these cases, these scenarios 




For the chart audits, the primary limitation is the strength of the documentation. 
The researcher relied on prior pathology, infectious disease, health maintenance, and 
provider documentation to determine when the appropriate follow-up should be. If the 
provider was using information not documented in one of these places to determine 
appropriate screening follow-up, the audit may not accurately reflect the appropriate 
follow-up interval due to information unknown to the researcher. Additionally, for 
Question two, the researcher marked the chart as a no if the current screening was done at 
an incorrect interval regardless of the reason. Different reasons noted included lack of 
follow-up by the patient, inappropriate screening interval chosen by the provider, change 
of patient between practices, and patient requests for a different screening interval. 
While this project did show an improvement in provider guideline adherence, it 
cannot be distinguished whether this improvement was a result of the educational session 
or the implementation of the notification, tracking and reminder system. The use of a 
smart phrase within the EHR that has pre-populated text and includes a default follow-up 
based on the guidelines for normal screening results as well as the educational session, 
both could have resulted in this improvement in follow-up recommendations found.  
There are also barriers, or limitations, of the ASCCP guidelines themselves that 
impact the provider’s ability to adhere to the guidelines. These guidelines rely heavily on 
past results in order to determine an appropriate screening interval. These results may be 
unavailable or may be given to the provider second hand from the patient without all of 
the necessary information known in order to make an accurate follow-up 
recommendation. Additionally, prior cases of failure to follow up can impact the current 




they are overdue for repeat screening. Question two, which asks whether the current 
screening was done at an appropriate interval from the last screening, was marked as no if 
the screening did not occur at an appropriate interval for any reason. This finding could 
have been due to patient non-compliance with follow-up recommendations or provider 
non-compliance with the guidelines and was not specified during data collection. This 
limits the interpretation of these data. 
Objective Two 
This objective was more difficult to evaluate statistically than Objective one. The 
survey questions designed to evaluate provider knowledge of the notification, tracking 
and reminder system all remained the same or improved following the roll out of the new 
system. Again, sample size limits the ability to apply this finding to a broader audience. 
Additionally, more research would need to be done to identify whether knowledge of, 
and confidence in the practice’s tracking and reminder system improves outcomes.  
The chart audits were done in order to evaluate compliance with the overall 
process. Slightly over one-quarter of the charts were not done correctly by the provider 
according to the process. If a provider missed the educational session, they were given 
the tip sheet and assisted with setting up their EHR short cuts by the nurse manager 
following the educational session. Additionally, there was a report built into the nursing 
process for the Pap pool that caught charts that were done incorrectly and ensured that 
they didn’t fall out of the new system. If a chart was identified that was done incorrectly 
by the provider, the provider was then contacted and reminded of the new process and the 
necessity of its use. Therefore, some providers were noted to do the process incorrectly 




Further audits may identify that the provider compliance with the process increases over 
time.  
Facilitators. The primary facilitator for this objective was the practice’s robust 
nursing leadership team. They, in conjunction with the provider champions, assisted in 
development and design of the tracking and reminder system in order to ensure that it 
was feasible within the current resources and structure of the practice. Additionally, the 
support of the EHR specialist was instrumental in designing this process. 
Barriers. The primary barrier to this objective was a lack of EHR build support. 
The practice has an EHR specialist who assisted with report writing, networking, and 
EHR functionality questions and served as a valuable resource during creation of the 
project. In order to build a new process into the EHR, however, the support of someone 
who is able to build functionality in was necessary. Build analysts for the EHR for this 
practice were shared with another large healthcare organization, which limited their 
availability to incorporate requested changes and answer questions as they arose, 
extending the length of the project overall. 
Another barrier to this objective was that some providers had already developed 
their own system for notification, tracking and reminding for cervical cancer and were 
hesitant to change to the new process. Providers were provided the opportunity to ask 
questions and given contact information in case they identified any opportunities for 
improvement with the new process. Additionally, the medical director sent an e-mail in 
support of the new process to all providers.  
The final barrier to implementation of this system was the time and resources 




discussion occurred regarding who would be best to manage the pool and whether a 
smaller group of nurses should pilot running it. Ultimately, this was decided to be the 
most feasible approach, and the nurse managers were identified as the group to run it. 
Practices looking to implement similar notification, tracking and reminder systems need 
to look at their current support staff availability and determine whether they have the 
resources necessary to successfully implement this type of process. For each result sent to 
the Pap pool, it takes the nurse approximately 10 minutes to complete the notification and 
enter the patient into the Pap pool system. Additional time will be required as the patient 
follow-up reminders begin to appear, estimated at 10 minutes per reminder. 
Unintended Consequences 
An unintended consequence of this project included increased work for nursing 
staff at the practice. While the new process is streamlined and more efficient than the 
prior process, the new project involves mailed notification for normal results as well as 
abnormal results. This was supported as best practice by the evidence but does increase 
the workload of the nursing staff (Slone et al., 2015). The workload and documentation 
for providers has not increased with this project, and for some providers may have 




Notification, Tracking and 
Reminder System 
 
The recommendation of the researcher is that this quality improvement project be 
continued and possibly expanded. The literature supports the need for an effective patient 




provider compliance with the guidelines. Use of features in the EHR such as point-of-
care reminders and patient reminders has been shown in other research to increase 
guideline compliance (Dupuis et al., 2010; Langsjoen et al., 2015; Shojania et al., 2011). 
While specific system features were not evaluated in this project, the recommendation 
would be to continue the new process that was developed and expand by possibly 
collecting longer term data on patient and provider guideline adherence.  
In discussion with nursing leadership and several providers, there seems to be a 
benefit to using a select nurse pool to manage quality improvement initiatives in areas 
such as cervical cancer screening. As the practice continues to grow, and with the focus 
of reimbursement focusing on quality of care indicators, there may be room in the future 
to expand the role of this nurse pool to include other screenings and quality measures. 
This would be done as a collaboration between providers and nursing, and the process 
designed for this project could be used as a template with modifications made for the 
specific initiative being managed. 
Provider Education Session 
From the research findings, it is unclear whether the educational session was 
effective and should be continued or replicated at other practices. Increased provider 
guideline adherence provides an evidence-based approach to care and decreases the 
number of unnecessary procedures that are done, reducing cost of both time and money 
and lessening the risk of psychological distress to the patient from having the procedure 
done (Cox, 2009; O’Connor et al., 2015). Further research on effective educational 




Congruence with Organization Objectives 
 
Continuing this new system aligns with the practice’s strategic model as a patient 
centered medical home by providing a consistent, evidence-based approach to cervical 
cancer screening and communication with both providers and patients. It allows for 
notification of patients to occur in a manner that has been demonstrated in the review of 
the literature to improve patient understanding of the follow-up recommendations and 
increases compliance with those reccomendations. Additionally, the tracking and 
reminder system gives the practice a well-designed tool for managing these complicated 
guidelines.  
Project Outcomes within the Theoretical Framework 
 
Use of the Donabedian framework for quality improvement was found to be 
particularly useful for this project. The three components of Donabedian’s theory are 
outcomes, structure, and process (Donabedian, 2005). For the scope of this project, 
patient outcomes were not evaluated. Extensive research already exists regarding the 
outcomes of use of the screening guidelines (Cox, 2009). The process component of this 
project focused on the provider knowledge and behaviors. There was not found to be a 
substantial change in this component of the quality improvement model. The final 
component, structure, is where this project was most impactful through implementation 
of the notificaiton tracking and reminder system. Implementation of an electronic 





Implications for Future Research 
The second chart audit looked at whether the current screening was done at a 
correct interval from the prior screening. In collecting this data, cases of follow-up that 
did not comply with the guidelines were not delineated by fallouts due to provider or 
patient non-compliance, so future research would be beneficial to evaluate only those 
fallouts that occurred due to provider non-compliance. Additionally, there are many 
reasons for the inaccurate follow-up. The provider may have been acting on a prior result 
note that indicated an improper screening interval when deciding whether to screen the 
patient or not at the current visit. They may also be screening more or less frequently due 
to patient request.  
Further research should be done to identify whether the identification of the 
correct follow-up interval, the first question for chart audits, would lead to longer term 
improvements in this second item being audited in the future. As the patient visits for 
future annual examinations and visits, the provider will see the prior result note with the 
correct recommendation and may be more likely to start completing the screening at an 
appropriate interval. For the scope of this project, charts were only audited to identify 
whether or not the recommendation or screening fell within the guidelines. It would be 
beneficial for additional research to be done to identify if there are specific screening 
findings or specific populations that are more likely to have an inappropriate follow-up 
done to assist in determining where best to focus future quality improvement initiatives.  
Finally, the educational session was created based on a history of cervical cancer 
screening, a review of evidence supporting the guidelines, and the risks of poor guideline 




educational session are more likely to improve guideline adherence. Additionally, 
presenting this educational session separately from the roll out of the new system may 
have improved the efficacy of the educational session. Discussion about the new process 
may have distracted providers during the educational session. 
Ongoing Evaluation 
 
Ongoing evaluation that will need to be continued outside of the scope of this 
project will be monitoring provider and nurse compliance with the notification, tracking 
and reminder system that was designed and implemented. The use of the report that the 
nurses will be compiling will serve to monitor provider compliance with the process. As 
the process continues to be used, there will likely be identified areas of improvement for 
ease of use or efficiency. The nurse educator, who was instrumental in providing insight 
into the process design and assisting with the roll out, will continue to manage the Pap 
pool and assist with any modifications to the process as necessary. There may be a need 
to expand the number of nurses who manage the Pap pool. The nurse educator, along 
with the nurse managers, will expand the pool and provide additional training as 
necessary in order to keep the workload at a manageable level. 
Application to Other Settings 
This project is very applicable to other primary care practices as well as other 
medical disciplines such as gynecology practices. The notification, tracking and reminder 
system, as well as the educational session, could be replicated and implemented within 
the framework of additional medical care settings. The chart review and survey process 
could also be replicated to identify both process and structure gaps in the management of 




certain conditions. Additionally, there exists a plethora of guidelines within healthcare. 
These guidelines have been created by experts in the field and are based off of evidence 
available regarding the most effective screening and treatment strategies. The findings of 
this project could be used to help identify and create further research and interventions 
aimed at improving compliance with other guidelines in practice.  
Reflections 
Through completion of this project, the researcher learned valuable lessons 
regarding creation and implementation of quality improvement initiatives. This included 
developing a project idea, completing an extensive review of the literature to determine 
the evidence-based intervention that will be used, developing a data collection plan, 
engaging stakeholders, process implementation, and analyzing results.  
In regard to creating a research project and plan, the data collection portion 
provided the greatest learning opportunity for the researcher. The survey, while a 
modified version of a validated national survey, required the student to anticipate the 
information that would be needed to effectively evaluate the objectives identified. The 
student learned that surveys, while easy to build and distribute to a large number of 
participants, can be complicated to develop. Questions and options need to be worded in 
a way that the risk of an incorrect interpretation of any of them does not invalidate the 
results. Additionally, analyzing and interpreting the data also presented a great learning 
opportunity for the student who, prior to this project, had limited experience with this 
portion of project planning and implementation.  
Finally, as a student preparing to enter practice, the most influential learning that 




use of guidelines in clinical practice. The consistent use of evidence-based guidelines 
gives providers the tools to provide high quality care to their patients and decreases 
liability on the part of the provider. There are numerous evidence-based guidelines and 
the research is constantly changing. As a provider, it is important to stay abreast of 
changes to guidelines and new research as it comes out in order to provide the highest 
quality care to patients. The use of resources and tools that are provided, such as the 
ASCCP application that the student recommended providers use, give the providers 
additional support and resources allowing them to practice efficiently and effectively.  
The student has observed and participated in care but has not directly provided 
unsupervised independent care in practice. Learning to develop and implement a process 
for which the student did not have extensive prior experience in presented some 
challenges. The guidance of the research committee as well as nursing and support staff 
at the practice were instrumental in the successful implementation of this project.  
The student’s current role as a nurse is in nursing leadership. This involves the 
analysis of problems and implementation of projects and interventions to address these. 
This experience served the student well in creating this project; however, key differences 
between implementation of a project at the nursing and provider levels were highlighted. 
The providers at this practice are passionate about, and take a lot of pride in, caring for 
their community and patients well. Medicine is both a science and an art and each 
provider has used their experiences to refine their craft. This project addressed the 
science of patient care; however, the art of it lies in conversations with patients, risk 
versus benefit discussions, and shared decision making that takes into consideration that 




practice nursing, is what is learned through experience and what the student will strive to 
hone after completion of this project and entry into practice.   
Essentials of Doctoral Education for 
Advanced Nursing Practice 
 
 The American Association of College of Nursing (2006) delineated eight 
competencies that they deem essential components of a Doctor of Nursing Practice 
(DNP) degree. These components are found throughout DNP programs curricula as well 
as throughout the course of completion of the DNP Scholarly project as the final 
requirement of the degree. The following section outlines the eight DNP essentials in the 
context of the completion of this quality improvement project. 
 The Essentials I through III focus on the preparation of the student to practice in 
an evidence-based manner, identify and implement processes to improve quality of care, 
and pursue the development of new research. Through the development of the project 
plan, the student was able to integrate of these essentials into practice. The American 
Association of Colleges of Nursing (2006) stated the student will, “Use science-based 
theories and concepts to . . . describe the actions and advanced strategies to enhance, 
alleviate, and ameliorate health and health care delivery phenomena as appropriate” (p. 
9). This was achieved through identification of the need to evaluate provider guideline 
adherence as well as the need for an improved notification, tracking and reminder system. 
Partnering with key end users in the organization, such as the nurse managers, allowed 
the student to exercise leadership and project management skills. Completion of the 
review of the literature and evaluation of the current state of practice, indicate the 




project aimed at improving quality of care, and collect outcomes data to evaluate the 
effectiveness of the project. 
 Essential IV focuses on the use of health information technology to assist in 
driving quality care. The EHR was a large component of this project, and the student 
gained a lot of experience in the benefits and limitations to the use of the EHR for quality 
improvement. Essential IV states that “Demonstrate the conceptual ability and technical 
skills to develop and execute an evaluation plan involving data extraction from practice 
information systems and databases” (American Association of Colleges of Nursing, 2006, 
p. 13). Through the creation of the chart audit report and completion of chart audits, the 
student was able to demonstrate this Essential component. Additionally, implementation 
of the new process into the EHR allowed the student to become more familiar with EHR 
functionality and ability to improve efficiency, quality, and safety when used to its fullest 
potential (Sullivan & Smolowitz, 2013). 
 Essentials V, VI, and VIII focus on the student’s ability to demonstrate 
interprofessional collaboaration, advocacy in health care policy, and advanced practice 
nursing. Throughout this project, the student was involved with many people in many 
positions and roles throughout the practice. Initially, the student met with the nurse who 
was managing the current system to evaluate what was in place and what gaps had 
already been identified. Following the review of the literature, the student met with 
provider leadership and nursing leadership several times to discuss the literature review 
findings and suggested project plan. The office managers were involved in assisting with 
scheduling the educatioanl sessions at each office. Additionally, the student met with the 




of this project required input and collaboration from multiple members of the healthcare 
team in order to create a robust, evidence-based process to serve the practice’s clients. 
This new process required a new workflow for providers and nurses, changing the policy 
of the way care is provided at the practice. Finally, analysis of the quality improvement 
data findings and synthesization of this information into practice implications became the 
culmination of the experience for the student. The DNP student was able to complete this 
project from start to finish, effectively learning and demonstrating competency in 
practicing nursing at an advanced level.  
 The final essential described is Essential VII, regarding clinical prevention and 
population health. These two components of healthcare are essential if the healthcare 
community is to continue to drive forward improved overall health and quality of life. 
Prevention, and focus of improved health on populations within the community, is the 
cornerstones of primary care practice. This project incorporated both prevention and 
population health considerations through the focus on guideline adherence.  
 The development and completion of this project allowed the DNP student to not 
only observe, but to be integrally involved in, what it means to continue to strive for both 
process and quality improvement in practice. The DNP degree is the terminal degree for 
nursing (American Association of Colleges of Nursing, 2006). “They [practice-focused 
doctoral programs] focus heavily on practice that is innovative and evidence-based, 
reflecting the application of credible research findings” (American Association of 
Colleges of Nursing, 2006, p. 3). Through completion of this project the student was able 




was allowed the opportunity to successfully demonstrate competency of all Essential 
elements of the DNP.  
Conclusion 
Despite limitations to this study, such as sample size that limit assumptions that 
can be made on the data, the new process served to address the need for implementation 
of a more efficient and sustainable notification, tracking and reminder system. This 
system is important in ensuring that patients receive proper screening for cervical cancer 
that achieves a balance between early identification of potential neoplasm and 
unnecessary testing or procedures done. It is also extremely important for organizations 
to have processes in place to notify, track, and remind their patients to follow up on any 
abnormal findings in order to continue to drive down mortality associated with cervical 
cancer.  
 Following implementation of this quality improvement project, providers were 
much more likely to correctly recommend follow-up to their patients after receiving their 
cervical cancer screening results. This improvement, however, did not necessarily 
correlate with practice as they were not any more likely to actually screen their patients at 
an appropriate interval post-intervention. Additionally, the survey findings indicated a 
slight improvement in provider guideline adherence on a series of patient scenarios. The 
small sample size limits the ability of these findings to be relied on for replication, 
however, does indicate that in this population there was a slight improvement.  
Additionally, the Pap pool was found to be an effective tool for notification, 
tracking and reminder systems as they were 100% compliant in chart audits following Go 




consistency is expected to improve as they become more familiar with the new system. 
Practices looking to improve provider guideline adherence and their structural approach 
to management of cervical cancer screening should consider implementation of a similar 
process. 
Following this project from initiation to completion gave the researcher valuable 
insight into the Essential elements that are expected to exist in all DNP curricula. While 
all eight elements were found throughout this project, particularly implementation of 
evidence-based practice and quality improvement were highlighted. Donabedian (2005) 
stated, “One is interested not in the power of medical technology to achieve results, but in 
whether what is now known to be ‘good’ medical care has been applied” (p. 694). Good 
medical care is that which, to the best of the provider’s ability, is based off of what 
current evidence supports as best practice for improving quality of care provided and 
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Notes/ Findings/ Findings 
 
Adherence to the 2012 National 
Cervical Cancer Screening 
Guidelines: A Pilot Study 
 
Teoh, D. G., Marriott, A. E., Vogel, R. I,, 
Marriott, R. T., Lais, C. W., Downs Jr., L. S., 








Survey of providers to determine knowledge of updated (3 years prior) 
cervical screening guidelines; Efforts should focus on improved provider 
and patient education, and methods that facilitate adherence to the 
guidelines such as electronic health record order sets. 
 
Current Practice Patterns in Cervical 
Cancer Screening in Indiana 
King, N. R., Kasper, K. M., Daggy, J. K., 
Edmonds, B. E. 
2014 Survey/ Level 
VI 
Vignette based survey. Most providers report following 2012 guidelines, 
however, many continue to screen more frequently than indicated. 
Discontent and Confusion: Primary 
Care Providers' Opinions and 
Understanding of Current Cervical 
Cancer Screening Recommendations 
Boone, E., Lewis, L., Karp, M. 2016 Survey/ Level 
VI 
Assessed provider's perceptions of updated guidelines. Findings: Distrust 
and confusion exist, leading to lack of compliance with guidelines and 
unnecessary screening and testing. 
Does a 30-min Quality Improvement 
Clinical Practice Meeting Reviewing 
The Recommended Papanicolau Test 
Guidelines for Adolescents Improve 
Provider Adherence to Guidelines in a 
Pediatric Primary Care Office? 




Provided an educational session at peds primary care office. After, saw 
significant decrease in unnecessary Paps and overall increased guideline 
compliance. 
Electronic Health Records and 
Ambulatory Quality of Care 
Kern, L. M., Barron, Y., Dhopeshwarkar, R. 
V., Edwards, A., Kaushal, R. 
2012 Cross Sectional 
Study/ Level IV 
Observes the effects of EHR implementation on screening practices across 
several screening modalities 
Improving Compliance with Cervical 
Cancer Screening Guidelines. 
Langsjoen, J., Goodell, C., Castro, E., 




Pilot/ Level IV 
Implemented point of care reminders in EPIC and an educational session 
for providers. Greatest improvement with HPV co-testing was noted in 
family practice. 
Provider Attitudes and Screening 
Practices Following Changes in Breast 
and Cervical Cancer Screening 
Guidelines 
Haas, J, S., Sprague, B. L., Klabunde, C. N., 
Tosteson, A. N., Chen, J. S., Bitton, A., 
Beaber, E. F., Onega, T., Kim, J. J., 
MacLean, C. D., Harris, K., Yamartino, P., 
Howe, K., Pearson, L., Feldman, S., 
Brawarsky, P., Schapira, M. M. 
2015 Survey/ Level 
VI 
Self-reported attitudes of providers via survey were assessed. Top reported 
barriers included patient perceptions, provider's disagreement with 
guidelines, performance based measures that conflict with guidelines, 





















Notes/ Findings/ Findings 
 
The Effects of On-Screen, Point of 
Care Computer Reminders on 
Processes and Outcomes of Care 
 
 
Shojania, K.G., Jennings, A., Mayhew, A., 








Literature review of studies looking at the impact of point of care 
reminders on provider behavior. Small to modest improvements were 
found utilizing point of care reminders.  
Cancer Screening Reminders: 
Addressing the Spectrum of Patient 
Preferences 
Brandzel, S. D.; Aiello Bowles, E. 
J.,Weineke, A.,; Bradford, S. C., Kimbel, K., 
Gao, H., Diana S.M. 
2017 Focus Group/ 
Level VI 
Assessed patient reminder preferences. Findings: Patients preferred 
personalized reminders and individually (not summary report annually) no 
more than three months prior to due for repeat screening. 
Inadequate Systems to Support Breast 
and Cervical Cancer Screening in 
Primary Care Practice 
Schapira, M. M., Sprague, B. L., Klabunde, 
C. N., Tosteson, A. N., Bitton, A., Chen, J. 
S., Beaber, E. F., Onega, T., MacLean, C. D., 
Harris, K., Howe, K., Pearson, L., Feldman, 
S., Brawarsky, P., Haas, J. S. 
 
2015 Survey / Level 
VI 
Focused on PCMH. Found that a lack of system support for screening for 
breast and cervical cancer exists. Looked specifically at clinical decision 
support, comparative performance reports, lack of an automated report 
system for patients overdue for screening, and lack of report of patients due 
for follow up. 
Inconsistencies Between Medical 
Records and Patient-Reported 
Recommendations for Follow-Up 
After Abnormal Pap Tests 
Slone, S., White, C. W., Shelton, B., Van 
Meter, E.; DeSimone, C. D., Schoenberg, N., 
Dignan, M.  
2013 Survey / Level 
VI 
Survey of patients understanding of follow up recommendations compared 
with actual recommendations Results: The most misunderstood directions 
were those that required gynecology follow-up or were more severe. 
Limitations- Done in rural Appalachia 
Pap Hub: A System to Improve 
Compliance with Pap Smear 
Screening Guidelines in a Large 
Healthcare System 
Teoh, D. G., Fall, L. A., Beitelspacher, E. A., 





Implemented a centralized pap hub that monitored results and sent 
notification and reminders. Nurses triaged normal results and provider did 
any abnormals. 
Patient Notification of Test Results in 
a Primary Care Setting 
Sullivan, C., Smolowitz, J. 2013 Retrospective 
Review/ Level 
VI 
Notification of both normal and abnormal test results should occur. Study 
found variation in methods used to notify patients and follow-up. 
Tracking Abnormal Cervical Cancer 
Screening: Evaluation of an EMR 
Based Intervention 
Dupuis, E. A., White, H. F., Newman, D., 




Created a report that was generated monthly showing patients who had not 























Notes/ Findings/ Findings 
 
Tracking and Reminder Systems 
 










Committee opinion on the need for, and reasons behind, an effective 
tracking and reminder system 
Making Healthcare Safer: A critical 
analysis of patient safety practices 






A report prepared for the AHRQ on safety practices. Section on critical 
results communication and follow up.  
Note. This table demonstrates articles included in the literature review regarding provider adherence to guidelines and patient 


















































Cervical Cancer Screening Survey 
 
Thank you for taking the time to take this survey. This survey was designed to collect 
data for a quality improvement project and was adapted from the AHRQ and CDC’s 
“National Survey of Primary Care Physicians’ Cancer Screening Recommendations and 
Practices”. Results are confidential and will be aggregated with other providers’ 
responses. Participation is voluntary but greatly appreciated.  
 
Survey Instructions: 
 Several questions are multiple choice.  
 Please mark the box of the corresponding answer that best fits your current 
clinical practice. 
 Assume all patients are otherwise healthy individuals with no history of 
immunocompromise or increased risk unless specified in the scenario. 
 
Part A: Provider Demographics 
 
A1. Degree (SELECT ONE) 
 MD/ DO  
 PA  
 NP 
 
A2. Age in years (SELECT ONE) 








A4. Years in practice (SELECT ONE) 
 < 5 
 5-10 
 > 10 years 
A5. Approximately what percentage of your patients in your main primary care practice 
is: (YOUR BEST ESTIMATE IS FINE) 
a. Under 18___________% 
b. 18-39 ______________% 
c. 40-64______________% 




A6. Approximately what percentage of your patients in your main primary care practice 
is female? (YOUR BEST ESTIMATE IS FINE)  
a. Female ____________% 
A7. During a typical year, for how many asymptomatic, average-risk female patients do 
you personally order or perform cervical cancer screening with Pap testing and/ or HPV 
testing? (SELECT ONE)  
 1-10 
 11-20 
 > 20 
 
Part B: Process 
B1. How effective do you believe the following screening procedures are in reducing 
cervical cancer mortality in average-risk women?  
 Very Effective Somewhat 
Effective 
Not Effective Effectiveness 
Not-known 
Pap test (liquid 
based cytology, 
e.g., Thin Prep® 
or SurePath®)  
 
    
HPV DNA test 
with Pap test  
    





Pap test)  
 




B2. In your clinical practice which cervical cancer screening guidelines do you follow?  
 American Society of Colposcopy and Cervical Pathology (ASCCP) 
 United States Preventative Taskforce Services (USPTS) 
 American College of Obstetricians and Gynecologists (ACOG) 
 Other:_______________________________________ 
B3. Assume that the following female patients present for a routine visit in your office. 








for the first 
time 1 month 
ago and is 
presenting 





 Pap + HPV testing 





 Every three years 
















 Pap + HPV testing 





 Every three years 














 Pap + HPV testing 





 Every three years 





who has no 
history of 
abnormal 
Pap smears  
 
 Pap 
 Pap + HPV testing 





 Every three years 












 Pap + HPV testing 





 Every three years 















 Pap + HPV testing 





 Every three years 














by you. The 





HPV as well. 
 
 Pap 
 Pap + HPV testing 





 Every three years 











her mid- 30’s 
 
 Pap 
 Pap + HPV testing 





 Every three years 





















 Repeat Pap cytology  
 Reflex HPV testing 




 Immediate  
 One year  
 Every three years 










 Repeat Pap cytology  
 Reflex HPV testing 




 Immediate  
 One year  
 Every three years 










 Repeat Pap cytology  
 Reflex HPV testing 




 Immediate  
 One year  
 Every three years 










 Repeat Pap cytology  
 Reflex HPV testing 




 Immediate  
 One year  
 Every three years 






 Repeat Pap cytology  
 Reflex HPV testing 
 Pap + HPV testing  
 Immediate  
 One year  






























 Repeat Pap cytology  
 Reflex HPV testing 




 Immediate  
 One year  
 Every three years 















 Repeat Pap cytology  
 Reflex HPV testing 




 Immediate  
 One year  
 Every three years 







B5. Are you following current screening guidelines on all of your patients? If no, why 
not? (SELECT ALL THAT APPLY) 
 I am following current screening guidelines 
 I do not know the current guidelines 
 I do not think guidelines are based on good data 
 I believe I have a higher-risk population 
 My patients are requesting more frequent screening 
 I am worried about missing high grade dysplasia or cancer in the interim 
 I am worried about being able to keep track of whether my patients complete 




Part C. Structure 
C1. Does your practice have a mechanism to remind you or other members of the care 
team that a patient is due for breast or cervical cancer screening? (SELECT ALL THAT 
APPLY)  
 Yes, special notation or flag in patient’s chart 
 Yes, computer prompt or computer-generated flow sheet 
 Yes, I routinely look it up in the medical record at the time of a visit 
 Yes, other mechanism (specify): ____________ 
 No 
 Don’t Know 
C2. Does your practice have a mechanism to remind your patients that they are due for 
cervical cancer screening? (SELECT ALL THAT APPLY) 
 Yes, verbal prompt from you or another member of the care team during an office 
visit 
 Yes, reminder by Mail 
 Yes, reminder telephone call 
 Yes, reminder by e-mail 
 Yes, other mechanism (specify): ____________ 
 No 




C3. Do you use any of the following resources for managing cervical cancer screening in 
practice? (SELECT ALL THAT APPLY)  
 Printed Guidelines 
 Website 
 Phone or tablet application 
 Patient Handouts 
 Other:________________________________________________________ 
 None of the above 
C4. Does your practice have a system to track patients who do not complete follow-up of 
an abnormal screening result? (SELECT ONE)  
 Yes 
 No 
 Not Sure 
C5. Does your practice have a mechanism to inform patients of abnormal results? 
(SELECT ALL THAT APPLY) 
 Yes, letter by US Mail 
 Yes, telephone call 
 Yes, email message 
 Yes, other method: ___________________________ 
 Don’t know 
 No 
Is there anything else you would like to mention about breast or cervical cancer screening 
in your practice or in general?  
 
 
Note: Survey adapted from the AHRQ and CDC’s “National Survey of Primary Care 


















Provider Educational Session Outline 
Part 1: Educational Session (20 minutes) 
1) Cervical Cancer Screening History 
a. Cervical Cytology 
b. HPV Genotyping 
c. 2012 ASCCP Guidelines 
2) Risks of Over Screening 
3) Findings from literature review regarding guideline adherence 
a. Guideline Compliance 
b. Use of the EHR 
c. Notification 
d. Tracking and Reminder Systems 
4) Review of practice survey findings 
5) Guideline Resources 
 
Part 2: Training on New System (20 minutes) 
1) Review of structure of new system and expectations 
2) Review and assist with setting up quick actions for routing result notes to the Pap 
pool 
 



















Chart Audits for Cervical Cancer Screening 
 
All patient records will be kept confidential and will not leave the property of the 
practice. No patient identifiers will be recorded or used nor will date of service. 
Individual testing results and diagnosis will not be included. Internal Review Board 
review and approval will be obtained as necessary per university and facility guidelines. 
The student is current with, and will remain throughout the duration of the project, 
Confidentiality Training. The student will retain all information extracted from the chart 
reviews in a secure site within AFM’s electronic network. No information will be 
transferred to a thumb drive or other external storage, and no paper information will leave 
AFM offices. The information presented in the capstone project paper will not include 
any patient health information that could potentially identify a patient.  
Adherence (pre and post data) 
1) Did recommended follow-up comply with either the preferred or acceptable 
options per the 2012 ASCCP Guidelines? (Use of the updated 2015 guidelines for 
primary HPV screening alone will be accepted as well) 
a. Yes 
b. No 
2) If available, did screening interval from last screening comply with the 2012 
ASCCP Guidelines? (Use of the updated 2015 guidelines for primary HPV 




Process (post data) 
3) Was a result note placed and routed to the PAP pool? 
4) Was a tickler placed in the patient’s system? 
5) Was a notification letter sent to the patient? 
 









































Dear Provider,  
 
My name is Amanda Miller DNP-S, BSN, RN. I am a Family Nurse Practitioner student 
at the University of Northern Colorado, pursuing a Doctor of Nursing Practice (DNP) 
degree. I have been working with Dr. Stephens and Dr. Klingner to conduct a quality 
improvement project on the management of cervical cancer screening in primary care. 
   
Participation in this DNP project involves completing confidential online surveys. The 
surveys will be confidential and unidentifiable to protect your privacy. The survey will 
take approximately 20-30 minutes to complete and will consist of multiple choice, select 
all that apply, and one free text question. You will have two weeks to complete the 
survey. Part of my project involves implementation of an electronic patient notification, 
tracking and reminder system for cervical cancer screening. Following implementation of 
this process and an optional educational session, a repeat survey will be sent following 
the same process as the first. 
 
Responses from this survey will remain confidential and will be used solely for the 
purpose of this study. Participation in the study is voluntary and you may withdraw 
participation at any time without penalty. Participants who complete the survey will be 
entered into a drawing for one of five $10 gift cards. This drawing will be completed 
following both the pre and post implementation surveys. Once you complete the survey, 
please notify your office manager to place your name on the list for the gift card drawing. 
There are no foreseeable risks that have been identified in the participation of this quality 
improvement project. Submission of this survey means that you are consenting to the 
participation in this project.  
 
This quality improvement project has been reviewed by the University of Northern 
Colorado Institutional Review Board and has been deemed acceptable in meeting the 
requirements intended to protect the rights and wellbeing of its participants. 
 
Survey link: https://unco.co1.qualtrics.com/jfe/form/SV_1X4hEktdDPVnWFn 
 
Should you have any questions or concerns please contact Amanda Miller at 
huff1824@bears.unco.edu or the Research advisor Dr. Jeanette McNeill at 
Jeanette.mcneill@unco.edu.  
 






























Note: Memorandum of understanding between the student and the clinical site for the 
DNP project. 
 
 
 
 
